0001209191-20-049796.txt : 20200908
0001209191-20-049796.hdr.sgml : 20200908
20200908200109
ACCESSION NUMBER: 0001209191-20-049796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200908
FILED AS OF DATE: 20200908
DATE AS OF CHANGE: 20200908
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saik Andrew
CENTRAL INDEX KEY: 0001616284
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 201165191
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
CITY: CHESTERBROOK
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VYNE Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics Inc.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-08
0
0001566044
VYNE Therapeutics Inc.
VYNE
0001616284
Saik Andrew
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER
NJ
08807
0
1
0
0
Chief Financial Officer
Common Stock
2020-09-08
4
P
0
40000
1.462
A
340000
D
These shares were purchased in multiple transactions at prices ranging from $1.4499 to $1.4767 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/ Mutya Harsch, attorney-in-fact for Andrew Saik
2020-09-08